Internal dosimetry for [4-14C]-cholesterol in humans

The main objective of this work is to provide a biokinetic model in order to estimate the radiometric dose due to intake of [4-14C]-cholesterol. The model was validated comparing the values of fecal excretion and absorption described in literature with that predicted by the model. The proposed model achieved good concordance between the results (p = 0.416 for excretion and p = 0.423 for absorption). The coefficients of effective dose (SvBq-1), equivalent dose (SvBq-1) and absorbed dose (GyBq-1) in human organs and tissues were calculated using the MIRD methodology and the compartmental analysis software ANACOMP. The coefficients were estimated for four phantoms: adult with a body mass of 73.3 kg, 15 years old adolescent (56.9 kg), 10 years old child (33.2 kg) and five years old child (19.8 kg). The organ that received the highest absorbed dose for all phantoms was the lower large intestine (LLI). The allometry theory was used to interpolate the coefficient of absorbed dose in the lower large intestine (DLLI) for unknown body mass (m): DLLI (GyBq-1)=161.26 m (kg)-1.025. For the same administered activity, the effective dose coefficient (E) decreases as the body mass increases. On other words, for the same intake activity, individuals with low body mass are exposed to higher doses. The allometry theory was used to interpolate the coefficient effective dose (E) for unknown body mass (m): E(SvB-1)= 171.1 m(kg)-1,021. (author)